|
|
Latest Story |
Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib's Potential as a Precision Medicine for Cancer |
GlobeNewswire |
Full Story → |
Headline News |
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update |
4:05p ET March 19 '24 GlobeNewswire |
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results |
4:05p ET March 13 '24 GlobeNewswire |
Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024 |
9:15a ET March 7 '24 GlobeNewswire |
More News → |
|
Today, 1:52p ET Friday April 26 '24. Markets Open. | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Previous data from yesterday, April 25 '24. |